Recent searches

No recent searches

Search options

Only available when logged in.
toad.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Mastodon server operated by David Troy, a tech pioneer and investigative journalist addressing threats to democracy. Thoughtful participation and discussion welcome.

Administered by:

Server stats:

234
active users

toad.social: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.4.1

#anticancer

0 posts0 participants0 posts today
Steve Dustcircle 🌹

Breakthrough #rice #bran #nanoparticles show promise as affordable and targeted #anticancer agent

eurekalert.org/news-releases/1

EurekAlert!Breakthrough rice bran nanoparticles show promise as affordable and targeted anticancer agent<p>Plant-derived nanoparticles have demonstrated significant anticancer effects. Researchers from Japan recently developed rice bran-derived nanoparticles (rbNPs) that efficiently suppressed cell proliferation and induced programmed cell death of only cancer cells. Furthermore, rbNPs successfully suppressed the growth of tumors in mice having aggressive adenocarcinoma in their peritoneal cavity, without any adverse effects. Given their low production costs and high efficacy, rbNPs hold great promise for developing affordable and safe anticancer agents.</p>
nemo™ 🇺🇦

#DKLS02 is a novel compound that has shown promising #anticancer activity in several cell line models, including melanoma, osteosarcoma, breast, prostate, pancreatic, cervical, ovarian, lung, and head and neck cancers.

ncbi.nlm.nih.gov/pmc/articles/

thehealthhorizon.com/showcases

eprints.qut.edu.au/244746/2/Ja

PubMed Central (PMC)Novel compounds in the treatment of lung cancer: current and developing therapeutic agentsLung cancer is the leading cause of cancer-related death in the United States. Though incremental advances have been made in the treatment of this devastating disease during the past decade, new therapies are urgently needed. Traditional cytotoxic agents ...
Continued thread
Manni_P :mastolove:

nature.com/articles/s41416-022

#Cellular and #MolecularBiology
#Cannabinoids as #anticancer drugs

#Cannabinoide #Cannabis

#Kipppunkte #biohazard #hanf #hemp #climatecrisis #COP28 🚰 ♿
#epigenetik #trauma #letztegeneration #Janov
#weedmob #climate #health #fridaysforfuture #antipro #Zukunft #ProtestCamp 🛏️ #spdbpt23 #CanG #EntkriminalisierungSofort 🛂

#EndFossilFuels #Gesundheit

#Ampel #DeutscheUmwelthilfe #BUND #ard #zdf #br24 ➡️ ❓#krebs #fossil #EndocrineDisruptors #Pestizide #Scholz #Berlin

NatureCannabinoids as anticancer drugs: current status of preclinical research - British Journal of CancerDrugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the life quality of cancer patients. From this perspective, cannabinoid compounds have been successfully tested as a systemic therapeutic option in a number of preclinical models over the past decades. As a result of these efforts, a large body of data suggests that the anticancer effects of cannabinoids are exerted at multiple levels of tumour progression via different signal transduction mechanisms. Accordingly, there is considerable evidence for cannabinoid-mediated inhibition of tumour cell proliferation, tumour invasion and metastasis, angiogenesis and chemoresistance, as well as induction of apoptosis and autophagy. Further studies showed that cannabinoids could be potential combination partners for established chemotherapeutic agents or other therapeutic interventions in cancer treatment. Research in recent years has yielded several compounds that exert promising effects on tumour cells and tissues in addition to the psychoactive Δ9-tetrahydrocannabinol, such as the non-psychoactive phytocannabinoid cannabidiol and inhibitors of endocannabinoid degradation. This review provides an up-to-date overview of the potential of cannabinoids as inhibitors of tumour growth and spread as demonstrated in preclinical studies.
TrendingLive feeds
About